capivasertib news

All news on capivasertib (also known as TRUQAP): plants, production capacities, investments and involved companies.

12 June 2026

Roche VENTANA PTEN (SP218) FDA-cleared as PTEN companion diagnostic in prostate cancer

First FDA-cleared IHC companion diagnostic to detect PTEN protein loss and select patients for capivasertib (TRUQAP) plus abiraterone therapy.

Who will be producing capivasertib in the future?

Find out with chemXplore Alpha

Learn more